Gefivid
Brand Name: Gefivid
Generic Name: Gefitinib
Active
Registration Number
DRP-12028
Dosage Form
Tablet
Issuance Date
May 31, 2022
Expiry Date
May 31, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength250mg
PackagingAlu/PVC Blister Pack x 10's (Box of 30's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antineoplastic [Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor]
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
GefitinibActive
Monograph: Gefitinib